Medicine for treating heart-kidney disorder schizophrenia and preparation method thereof

Abstract

The invention discloses a medicine for treating the heart and kidney imbalanced schizophrenia and a preparing method thereof. The medicine comprises an oral medicine and an external medicine. The oral medicine comprises raw medical materials including gypsum rubrum, cape jasmine, bamboo leaves, coptis chinensis, bistort rhizome, dried radix rehmanniae, radix scrophulariae, cornu bubali, chlorite schist, lumbricus, radix polygoni multiflori preparata, flos rosae rugosae, prunus mume, apiary, radix ranunculi ternate, stiff silkworm, bamboo juice, tabasheer, platycodon grandiflorum, lily, asparagus cochinchinensis, radix polygonati officinalis, sealwort, fructus lycii, glossy privet fruit, mulberry, tortoise shell, folium artemisiae argyi, root of Chinese trichosanthes, spina date seed, platycladi seed, valerian, polygala tenuifolia and acorus gramineus. The external medicine comprises the raw medical materials including angelica sinensis, Chinese prickly ash, polygala tenuifolia, cinnamon, lotus root starch, bighead atractylodes rhizome, aloe and costustoot. The medicine for treating the heart and kidney imbalanced schizophrenia has the advantages that the theory of traditional Chinese medicine is utilized, nourishing yin, suppressing the excessive yang and restoring normal coordination between the heart and the kidney are primary, the medicine has the effects of being quick in effect, definite in therapeutic effect and high in safety performance in treating the heart and kidney imbalanced schizophrenia, no toxic and side effect is produced, and the heart and kidney imbalanced schizophrenia is not prone to relapse.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a medicine for treating heart-kidney disorder schizophrenia and a preparation method thereof. Background technique [0002] Schizophrenia is a group of severe mental illnesses of unknown etiology, mostly in young adults with slow or subacute onset, clinically manifested as a syndrome with various symptoms, involving obstacles in perception, thinking, emotion, and behavior and incoordination of mental activity. Patients generally have clear consciousness and basically normal intelligence, but some patients may experience cognitive impairment during the course of the disease. The course of the disease is generally protracted, showing recurrent attacks, aggravation or deterioration, and some patients eventually develop decline and mental disability, but some patients can maintain recovery or basically recovery after treatment. [0003] Schizophrenia is a clinical syndrome compose...

AI Technical Summary

Problems solved by technology

(4) Disorders of will and behavior. Most patients have decreased or even lack of will, manifested as reduced activities, being alone, passive behavior, lack of due enthusiasm and initiative, decreased interest in work and study, no concern for the future, and lack of concern for the future. No definite intention, some patients may have some plans and intentions, but seldom carry out

[0005] Currently, long-acting injections such as risperidone and paliperidone are commonly used in the treatment of schizophrenia by western medicine. The treatment of schizophrenia by western medicine takes a long time, has many adverse reactions, and is prone to drug resistance. There are fewer types of drugs and limited choices. , and the price is expensive, the patient's economic burden is heavy, and the patient's long-term social and psychological problems will also bring mental pressure, and even aggravate the condition, causing great pain to the patient